Tuanmao Guo1, Yanli Xing2, Haiyun Zhu1, Lan Yang1, Yuan Xiao1, Jiang Xu1. 1. Department of Orthopedics, Xianyang Central Hospital, Xianyang, 712000, People's Republic of China. 2. Department of Pharmacy, Xianyang Central Hospital, Shanxi Province, No. 78, Renmin East Road, Xianyang, 712000, People's Republic of China. 15389460555@163.com.
Abstract
It has been reported that osteoporosis is a possible risk factor of benign paroxysmal positional vertigo (BPPV). PURPOSE: We analyzed the correlation between osteoporosis and BPPV and the possible mechanism by performing evidence-based medicine meta-analysis and bioinformatics analysis. METHODS: Initially, English articles related to osteoporosis and BPPV were obtained through PubMed and EMBASE databases. Stata12.0 software was used for meta-analysis to calculate the odd ratio (OR) and 95% confidence interval (CI) of outcome indicators, and the heterogeneity was evaluated by subgroup analysis, publication bias evaluation, and sensitivity analysis. In addition, microarray datasets related to BPPV and osteoporosis were obtained from gene expression omnibus (GEO) database to screen differentially expressed genes. At last, a mouse model of osteoporosis was established by bilateral oophorectomy for validation. RT-qPCR and Western blot analysis were performed to determine expression of related factors in mouse tissues. RESULTS: Osteoporosis was suggested as an important risk factor for BPPV through meta-analysis of these 12 articles. It was found that PPP2CA was upregulated in BPPV and low bone mineral density (BMD) samples. Moreover, PPP2CA induced dephosphorylation of BCL2, which may be involved in BPPV through regulation of BMD. Through this mechanism, silencing of PPP2CA could elevate the incidence of BPPV by promoting bone remodeling and reducing the density of otoconia around the macula. CONCLUSIONS: PPP2CA reduces BMD expression by inducing dephosphorylation of BCL2, which may be one of the mechanisms responsible for the onset of BPPV in osteoporosis.
It has been reported that osteoporosis is a possible risk factor of benign paroxysmal positional vertigo (BPPV). PURPOSE: We analyzed the correlation between osteoporosis and BPPV and the possible mechanism by performing evidence-based medicine meta-analysis and bioinformatics analysis. METHODS: Initially, English articles related to osteoporosis and BPPV were obtained through PubMed and EMBASE databases. Stata12.0 software was used for meta-analysis to calculate the odd ratio (OR) and 95% confidence interval (CI) of outcome indicators, and the heterogeneity was evaluated by subgroup analysis, publication bias evaluation, and sensitivity analysis. In addition, microarray datasets related to BPPV and osteoporosis were obtained from gene expression omnibus (GEO) database to screen differentially expressed genes. At last, a mouse model of osteoporosis was established by bilateral oophorectomy for validation. RT-qPCR and Western blot analysis were performed to determine expression of related factors in mouse tissues. RESULTS: Osteoporosis was suggested as an important risk factor for BPPV through meta-analysis of these 12 articles. It was found that PPP2CA was upregulated in BPPV and low bone mineral density (BMD) samples. Moreover, PPP2CA induced dephosphorylation of BCL2, which may be involved in BPPV through regulation of BMD. Through this mechanism, silencing of PPP2CA could elevate the incidence of BPPV by promoting bone remodeling and reducing the density of otoconia around the macula. CONCLUSIONS: PPP2CA reduces BMD expression by inducing dephosphorylation of BCL2, which may be one of the mechanisms responsible for the onset of BPPV in osteoporosis.
Authors: Guy R Watkins; Ning Wang; Matthew D Mazalouskas; Rey J Gomez; Chris R Guthrie; Brian C Kraemer; Susann Schweiger; Benjamin W Spiller; Brian E Wadzinski Journal: J Biol Chem Date: 2012-05-21 Impact factor: 5.157
Authors: Sara Reynhout; Sandra Jansen; Dorien Haesen; Siska van Belle; Sonja A de Munnik; Ernie M H F Bongers; Jolanda H Schieving; Carlo Marcelis; Jeanne Amiel; Marlène Rio; Heather Mclaughlin; Roger Ladda; Susan Sell; Marjolein Kriek; Cacha M P C D Peeters-Scholte; Paulien A Terhal; Koen L van Gassen; Nienke Verbeek; Sonja Henry; Jessica Scott Schwoerer; Saleem Malik; Nicole Revencu; Carlos R Ferreira; Ellen Macnamara; Hilde M H Braakman; Elise Brimble; Maura R Z Ruzhnikov; Matias Wagner; Philip Harrer; Dagmar Wieczorek; Alma Kuechler; Barak Tziperman; Ortal Barel; Bert B A de Vries; Christopher T Gordon; Veerle Janssens; Lisenka E L M Vissers Journal: Am J Hum Genet Date: 2018-12-27 Impact factor: 11.025
Authors: Stephen L Kopecky; Douglas C Bauer; Martha Gulati; Jeri W Nieves; Andrea J Singer; Peter P Toth; James A Underberg; Taylor C Wallace; Connie M Weaver Journal: Ann Intern Med Date: 2016-10-25 Impact factor: 25.391
Authors: So Young Kim; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Joong Seob Lee; Hyo Geun Choi Journal: Int J Environ Res Public Health Date: 2022-08-18 Impact factor: 4.614